Wednesday, 06 May 2020
  1 Replies
  3.7K Visits
0
Votes
Undo
Modulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in mice.
Skurikhin EG, Pershina OV, Reztsova AM, Ermakova NN, Khmelevskaya ES, Krupin VA, Stepanova IE, Artamonov AV, Bekarev AA, Madonov PG, Dygai AM.
PLoS One. 2015 Apr 30;10(4):e0125065. doi: 10.1371/journal.pone.0125065. eCollection 2015.
PMID: 25927611

Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis.
Kai Y, Yoneyama H, Koyama J, Hamada K, Kimura H, Matsushima K.
Med Mol Morphol. 2007 Sep;40(3):128-40. doi: 10.1007/s00795-007-0370-y. Epub 2007 Sep 18.
PMID: 17874045
more than a month ago
·
#31
0
Votes
Undo
Hi Anna,
Thanks for posting these publications.
What do you think these papers are telling us about the potential to use hyaluronidase and chondroitinase for the lung pathology associated with COVID-19?
BW
Tony
  • Page :
  • 1
There are no replies made for this post yet.
Be one of the first to reply to this post!

We are expanding the Membership of the Society!

Apply to be a Member or Trainee Member of ISHAS

For ISHAS Members:

Board vacancies from 2022: 3 Trustees, Secretary & President-Elect

Log in